Dechra Pharmaceuticals plc. Is a pharmaceutical company that develops, manufactures and markets veterinary pharmaceutical products worldwide. Founded in 1997 by way of a buyout from Lloyds Chemist. The company has operations in Europe as well as North America in addition to running a pharmaceutical research center.
The company’s pipeline of pharmaceuticals is made up of products for endocrinology, dermatology analgesia, and other critical care products for dogs and cats and poultry vaccines. The company bought Danish veterinary product business VetXX for £62 million in 2007. In 2013, it divested its veterinary service business to Patterson Companies for £87.5 million.
Dechra Pharmaceuticals plc. is also engaged in the production and distribution of pet nutrition products. It also develops manufactures and regulates crop production.
Dechra Pharmaceuticals plc. went public in 2000 and was listed on the London Stock Exchange.